VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,079,193 | +5.9% | 40,104 | +18.5% | 0.15% | +4.9% |
| Q2 2023 | $1,019,357 | -22.1% | 33,854 | -16.3% | 0.14% | -29.8% |
| Q1 2023 | $1,309,090 | +37.9% | 40,466 | +22.2% | 0.20% | +15.2% |
| Q4 2022 | $949,264 | +19.0% | 33,122 | +0.2% | 0.18% | +18.7% |
| Q3 2022 | $798,000 | -5.0% | 33,068 | +16.1% | 0.15% | -9.1% |
| Q2 2022 | $840,000 | -25.2% | 28,475 | -11.1% | 0.16% | -5.7% |
| Q1 2022 | $1,123,000 | +292.7% | 32,038 | +158.2% | 0.18% | +94.4% |
| Q1 2020 | $286,000 | -31.2% | 12,409 | -12.7% | 0.09% | -33.8% |
| Q4 2019 | $416,000 | – | 14,208 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |